Author: Site Editor Publish Time: 10-30-2026 Origin: Site
Proper reconstitution and adequate dilution help reduce particle aggregation.
Correct injection depth and even product distribution are central to PLLA nodule prevention.
Appropriate treatment intervals and aftercare support consistent clinical management.
Poly-L-lactic acid (PLLA) fillers are widely used for gradual facial volume restoration and collagen stimulation. However, nodules remain a concern in PLLA treatment, particularly when particles are not properly prepared or evenly distributed. Understanding how product preparation, injection technique, and treatment planning affect nodule formation is essential for how to reduce nodule risk after PLLA injection.
PLLA nodules can develop when particles accumulate in localized areas and trigger a foreign-body response. Dilution affects particle concentration and helps achieve more even distribution within the injected suspension.
Expert recommendations commonly suggest 8–12 mL of sterile water for injection per vial, with higher volumes used for some treatment areas. The appropriate volume depends on the product formulation, anatomical site, and treatment plan.
Proper PLLA reconstitution is equally important. Particles need sufficient time to hydrate and form a homogeneous suspension before injection. Poorly hydrated particles may remain in aggregates and contribute to nodule formation. Follow the specific product instructions for reconstitution and storage.
PLLA is commonly injected into the deep subcutaneous plane. Superficial intradermal placement increases the risk of visible papules, palpable nodules, and surface irregularities. Careful anatomical assessment is essential to ensure that the product is deposited in the intended tissue plane.
PLLA stimulates collagen production around its particles. Local product accumulation can lead to uneven tissue responses and increase nodule risk.
Controlled retrograde linear injection and fanning techniques help distribute the suspension across the treatment area. The needle or cannula should move during product delivery to avoid excessive deposition at a single point. Large, concentrated bolus deposits should be avoided. A consistent PLLA injection technique helps distribute particles more evenly and reduces unnecessary local accumulation.
PLLA treatment is usually performed over 2–3 sessions rather than injecting a large amount of product in one visit. Many treatment plans use intervals of approximately 6–8 weeks.
This spacing gives practitioners time to assess collagen development and tissue response before deciding on further treatment. It also helps avoid excessive product accumulation from overlapping treatment sessions. The number of sessions and intervals should reflect the patient's response, treatment area, and product instructions.
The 5-5-5 massage rule is widely used after PLLA treatment: massage for 5 minutes, 5 times a day, for 5 days. However, massage is a supporting aftercare measure, not the main method of PLLA nodule prevention. It cannot compensate for inadequate dilution, poor particle hydration, or incorrect injection technique. Its use should follow the specific product's aftercare protocol.
For early, small, non-inflammatory nodules, clinical assessment and appropriate massage may be considered. Persistent nodules or those accompanied by redness, pain, or swelling require further evaluation and management based on their underlying cause.
Nodule prevention is an important part of successful PLLA treatment. Beyond reducing complications, it helps clinics maintain consistent treatment standards and build patient confidence. Contact Dermax to discuss PLLA product details, bulk supply, and professional cooperation opportunities.
content is empty!
